Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different concentrations and volumes of periarticular cocktail injection after total knee arthroplasty
ChiCTR2400079342Phase 4Not yet recruiting
- Sponsor
- Shengjing Hospital of China Medical University
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ropivacaine and ketorolac in knee osteoarthritis (OA) (2 arms), sponsored by Shengjing Hospital of China Medical University. Primary endpoints: Circumferential diameter of the knee joint on the surgical side and Pain rebound time. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
ropivacaineketorolac
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2400079342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079342.